Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07504965 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly

Study acronym: DARE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The DARE study (Dementia-Friendly Apothecaries as a Resource for Mental Health in the Elderly) is a multicenter, prospective cohort study aiming to identify individuals with cognitive impairments early in pharmacies and enhance their access to support services. Partner pharmacies are equipped with memory test stations, and pharmaceutical staff are trained to guide participants. The digital memory test evaluates cognitive, psychosocial, and health factors, displaying results in a traffic light graphic. Participants with concerning results are referred to specialists or support services. The study's primary goals are to establish pharmacies as dementia screening hubs, improve care for affected individuals, promote interdisciplinary collaboration, and lay the groundwork for legal and billing frameworks. An optional subproject validates the screening through neurological evaluations.
Trial Details
NCT Number NCT07504965
Lead Sponsor Ludwig-Maximilians - University of Munich
Collaborators: Bayerisches Staatsministerium für Gesundheit, Pflege und Prävention
Conditions
(from sponsor)		 Mild Cognitive Impairment, Mild Dementia
Related terms Cognitive Dysfunction
Enrollment 1,020 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov